Skyscape Web Viewer : The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs : Medication Index

View All
Temazepam Benzodiazepines Solutions and suspensions Tapering When and Why to Stop Benzodiazepines and Z-Drugs Z drugs (benzodiazepine receptor agonists) Making Up Smaller Doses of Benzodiazepines and Z-Drugs Practically Switching to Longer-Acting Benzodiazepines to Taper Temazepam When and Why to Stop Gabapentinoids
Tranxene
Tranylcypromine Factors Influencing Development of Withdrawal Effects Phenelzine Solutions and suspensions Tranylcypromine Antidepressants Mis-Diagnosis of Withdrawal Effects As Relapse Recent Developments in the Understanding of Antidepressant Withdrawal Tapering
Trazodone Antidepressants Factors Influencing Development of Withdrawal Effects Other Considerations in Tapering Benzodiazepines and Z-Drugs Receptor occupancy, Tapering Dilutions Managing Complications of Antidepressant Discontinuation Practical Options in Prescribing Gradually Tapering Doses of Antidepressants Solutions and suspensions Trazodone
Trazodone Hydrochloride
Triazolam Management of Complications of Benzodiazepine and Z-Drug Discontinuation Solutions and suspensions Tapering Triazolam Z drugs (benzodiazepine receptor agonists) Benzodiazepines Receptor occupancy, Switching to Longer-Acting Benzodiazepines to Taper The Neurobiology of Tapering Withdrawal Symptoms During Benzodiazepine Maintenance Treatment
Trimipramine Stratfiying Risk of Antidepressant Withdrawal Factors Influencing Development of Withdrawal Effects
Tegretol
Tofranil
Tranylcypromine Sulfate